OptimizeRx Corp (NAS:OPRX)
$ 10.54 -0.27 (-2.5%) Market Cap: 191.66 Mil Enterprise Value: 219.54 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 77/100

OPTIMIZERx Corp at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2023 / 08:05PM GMT
Release Date Price: $12.15 (-2.64%)
Sean Dodge
RBC Capital Markets - Analyst

Good afternoon, and thanks, everybody, for coming out to RBC's 2023 global healthcare conference. My name is Sean Dodge, the HCIT analyst here at RBC. And I'm pleased to be joined by our next presenting company, OptimizeRx. And here on behalf of the company is their Chief Executive Officer, Will Febbo. It's a Will special. Thanks to you for joining us here.

Will Febbo
OptimizeRx Corporation - CEO & Director

Thanks, Sean.

Questions & Answers

Sean Dodge
RBC Capital Markets - Analyst

Let's start. You guys have been going through this exciting evolution from the kind of the terms you've used kind of migrating away from the traditional tactical work to these more kind of data rich, real world data, AI engagements. Maybe just give us a little bit of a background there and kind of what's unfolding.

Will Febbo
OptimizeRx Corporation - CEO & Director

Yeah. So just for context, we -- pharmaceutical manufacturers are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot